President Trump’s opioid commission last week focused on health insurance companies’ role in contributing to the addiction crisis. The commission is scheduled to deliver its final report on November 1.
Representative Tom Marino of Pennsylvania announced this week he is withdrawing his name from consideration as head of the White House Office of National Drug Control Policy. His decision comes in the wake of a Washington Post and 60 Minutes joint report that concluded legislation Marino sponsored hampered efforts by the Drug Enforcement Administration to fight the opioid epidemic.
Health insurer Cigna announced this week it will stop covering the prescription opioid OxyContin in an effort to reduce inappropriate use of the drug. Instead it will cover an equivalent drug less vulnerable to being misused.
Drug company and government officials announced new efforts designed to fight opioid addiction during a meeting this week of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
President Trump this week promised to win the fight against the opioid epidemic, but declined to act on a recommendation to declare a national emergency. He offered no new recommendations, Reuters reports.
At least 17 states have passed laws limiting painkiller prescribing, The Washington Post reports. Some states have enacted measures that limit opioid prescriptions to five or seven days, while others have passed dosage limits.
There was an overall decline in the amount of opioids prescribed in the United States between 2010 and 2015, but the quantity of prescriptions is still extremely high, according to a new government report.